NCT04933786 is a NA clinical trial of Digital Health Nudging in Congenital Heart Disease, sponsored by Deutsches Herzzentrum Muenchen.

Who is sponsoring NCT04933786?

NCT04933786 is sponsored by Deutsches Herzzentrum Muenchen.

What drugs are being tested in NCT04933786?

Interventions in NCT04933786: Digital Health Nudging.

What condition does NCT04933786 study?

NCT04933786 studies Congenital Heart Disease.

Is NCT04933786 still recruiting?

NCT04933786 is currently completed. Last updated 4 January 2023.

Last reviewed 2023-01-04 · How we verify

NCT04933786

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Digital Health Nudging in Adolescents With Congenital Heart Disease

Completed NA Last updated 4 January 2023

What this trial tests

NA trial testing Digital Health Nudging in Congenital Heart Disease in 97 participants. Completed in 1 November 2022.

Timeline

1 June 2021

Primary endpoint
1 November 2022

1 November 2022

Quick facts

Lead sponsor	Deutsches Herzzentrum Muenchen
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	crossover
Masking	none
Primary purpose	prevention
Enrollment	97
Start date	1 June 2021
Primary completion	1 November 2022
Estimated completion	1 November 2022
Sites	1 location across Germany

Drugs / interventions tested

Digital Health Nudging

Conditions studied

Congenital Heart Disease — all drugs for Congenital Heart Disease →

Sponsor

Deutsches Herzzentrum Muenchen — full company profile →

Who can join

Adults 12 to 18, any sex, with Congenital Heart Disease. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

In adolescents with congenital heart disease physical activity level is reduced which is why promotion to a more active lifestyle with an age-appropriate and modern intervention is needed. In healthy subjects digital health nudging was shown to increase physical activity. However, in adolescents with congenital heart disease such studies have not been conducted yet. In this RCT participants receive daily, short smartphone messages with the primary purpose to increase daily physical activity, which is monitored with a "Garmin vivofit jr." wearable.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Digital Health Nudging to increase physical activity in pediatric patients with congenital heart disease: A randomized controlled trial.
Willinger L, Oberhoffer-Fritz R, Ewert P, Müller J. · · 2023 · cited 8× · PMID 37030491 · DOI 10.1016/j.ahj.2023.04.001

Verify or expand the search:

Other recruiting trials for Congenital Heart Disease

Currently open trials in the same condition.

NCT07193719 — Influence of Personalized Lung Volume Optimization Maneuver on Lung Function and Cardiac Performance in Children · Phase 1, PHASE2 · recruiting
NCT07023367 — Parent Navigator Program (PNP) to Improve Outcomes in Latino/x Children and Parents · NA · recruiting
NCT06833320 — Propranolol Treatment for Postoperative Chylothorax · Phase 1, PHASE2 · recruiting
NCT06668389 — Sodium-Glucose Cotransporter 2 Inhibitors for Repaired Tetralogy of Fallot Patients for Enhancement of Cardio-Pulmonary · Phase 4 · recruiting
NCT06872320 — The Influence of Probiotics on Metabolome and Heart Rate Variability in Heart Failure of Structure Heart Disease · NA · active not recruiting

Other Deutsches Herzzentrum Muenchen trials

Trials by the same sponsor.

NCT07344480 — Retrospective Natural History Study of RASopathy-associated Cardiomyopathy (RAS-CM) · recruiting
NCT06369142 — Intracoronary Stenting and Additional Results Achieved by ShockWAVE Coronary Lithotripsy · NA · recruiting
NCT06753227 — Invasive Versus Echocardiography-derived Transvalvular Gradients After TAVI Usign Balloon-expandable Transcatheter Heart · enrolling by invitation
NCT06814574 — Pacemaker Implantation Following Transcatheter Tricuspid Valve Replacement · recruiting
NCT06060912 — LAmbre Versus AMPLATZER Amulet Left AtrIal Appendage Occluder for StRoke ProphylaxIs · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04933786 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Deutsches Herzzentrum Muenchen
Last refreshed: 4 January 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04933786.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing